These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4602984)

  • 21. Portable device for quantifying parkinsonian wrist rigidity.
    Caligiuri MP
    Mov Disord; 1994 Jan; 9(1):57-63. PubMed ID: 7908119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The treatment of Parkinson tremors and forms of extrapyramidal tremors with methixene. A multicenter study].
    Volles E; Fredrich H
    Med Welt; 1983 Jun; 34(24):707-9. PubMed ID: 6888239
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report.
    Wycis HT
    Confin Neurol; 1972; 34(1):130-5. PubMed ID: 5084387
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of parkinsonian syndromes in developing countries.
    Ogunniyi A
    Afr J Med Med Sci; 1997; 26(1-2):101-3. PubMed ID: 10895245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transdermal selegiline (Emsam).
    Med Lett Drugs Ther; 2006 May; 48(1235):41-2. PubMed ID: 16770292
    [No Abstract]   [Full Text] [Related]  

  • 26. Quantification of the effects of muscle relaxant drugs in man by tonic stretch reflex.
    Meyer M; Adorjáni C
    Adv Neurol; 1983; 39():997-1011. PubMed ID: 6660131
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experience with amysil treatment of patients with vascular parkinsonism].
    Kamenetskiĭ VK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(9):56-9. PubMed ID: 2692361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Future therapies for Parkinson's disease.
    Hauser RA; Lyons KE
    Neurol Clin; 2004 Oct; 22(3 Suppl):S149-66. PubMed ID: 15501363
    [No Abstract]   [Full Text] [Related]  

  • 29. Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease.
    Navan P; Findley LJ; Jeffs JA; Pearce RK; Bain PG
    Mov Disord; 2003 Feb; 18(2):176-80. PubMed ID: 12539211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Statokinesimetric study of the effect of minaprine on tonic postural activity in akineto-hypertonic Parkinson patients].
    Valade D; Baron JB
    Agressologie; 1983 Jan; 24(1):47-55. PubMed ID: 6869694
    [No Abstract]   [Full Text] [Related]  

  • 31. Current status of selegiline as a neuroprotective agent in Parkinson's disease.
    Olanow CW; Mytilineou C; Tatton W
    Mov Disord; 1998; 13 Suppl 1():55-8. PubMed ID: 9613720
    [No Abstract]   [Full Text] [Related]  

  • 32. [Between Scylla and Charybdis: drug-induced psychosis in patients with Parkinson disease].
    Kuiper MA; Zwaan WA; Wolters EC
    Ned Tijdschr Geneeskd; 1994 Jul; 138(27):1353-7. PubMed ID: 8035892
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment options for early Parkinson's disease.
    Stacy M; Brownlee HJ
    Am Fam Physician; 1996 Mar; 53(4):1281-7. PubMed ID: 8629572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical investigation of medicinal products in the treatment of Parkinson's disease (CPMP note for guidance). European Agency for Evaluation of Medicinal Products.
    Eur Neuropsychopharmacol; 1999 Sep; 9(5):443-9. PubMed ID: 10523052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amantadine hydrochloride in treatment of Parkinsonism.
    Nagaswami S; Nagaswami R
    Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
    [No Abstract]   [Full Text] [Related]  

  • 36. Are there clinically significant differences between dopamine agonists.
    Stocchi F; Vacca L; Onofrj M
    Adv Neurol; 2003; 91():259-66. PubMed ID: 12442684
    [No Abstract]   [Full Text] [Related]  

  • 37. Randomized trial of pallidotomy versus medical therapy for Parkinson's disease.
    Vitek JL; Bakay RA; Freeman A; Evatt M; Green J; McDonald W; Haber M; Barnhart H; Wahlay N; Triche S; Mewes K; Chockkan V; Zhang JY; DeLong MR
    Ann Neurol; 2003 May; 53(5):558-69. PubMed ID: 12730989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does thalamotomy alter the course of Parkinson's disease?
    Tasker RR; DeCarvalho GC; Li CS; Kestle JR
    Adv Neurol; 1996; 69():563-83. PubMed ID: 8615182
    [No Abstract]   [Full Text] [Related]  

  • 39. The nurse's role in clinical trials.
    Amyot D; Gray P; Demong C; Wilson W; Murphy D; Watson J; Duff J
    Can Nurse; 1996 Nov; 92(10):30-2. PubMed ID: 9095759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and pharmacological evaluation of the effects of piribedil in patients with parkinsonism.
    McLellan DL; Chalmers RJ; Johnson RH
    Acta Neurol Scand; 1975 Jan; 51(1):74-82. PubMed ID: 1091122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.